Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Bridgebio Pharma Inc (BBIO)

Bridgebio Pharma Inc (BBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,277,993
  • Shares Outstanding, K 175,832
  • Annual Sales, $ 9,300 K
  • Annual Income, $ -643,200 K
  • 60-Month Beta 1.03
  • Price/Sales 473.08
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade BBIO with:

Options Overview Details

View History
  • Implied Volatility 77.15% ( -6.26%)
  • Historical Volatility 37.75%
  • IV Percentile 68%
  • IV Rank 14.94%
  • IV High 241.04% on 07/14/23
  • IV Low 48.37% on 11/24/23
  • Put/Call Vol Ratio 0.04
  • Today's Volume 1,295
  • Volume Avg (30-Day) 1,534
  • Put/Call OI Ratio 0.61
  • Today's Open Interest 104,609
  • Open Int (30-Day) 100,733

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -0.40
  • Number of Estimates 6
  • High Estimate 0.86
  • Low Estimate -1.08
  • Prior Year -0.92
  • Growth Rate Est. (year over year) +56.52%

Price Performance

See More
Period Period Low Period High Performance
1-Month
23.68 +5.07%
on 04/25/24
31.23 -20.33%
on 03/27/24
-4.88 (-16.40%)
since 03/26/24
3-Month
23.68 +5.07%
on 04/25/24
41.04 -39.38%
on 02/15/24
-11.06 (-30.77%)
since 01/26/24
52-Week
12.75 +95.14%
on 05/25/23
44.32 -43.86%
on 12/28/23
+10.59 (+74.11%)
since 04/26/23

Most Recent Stories

More News
Stock Indexes Rally to Record Highs on a Resilient US Economy

The S&P 500 Index ($SPX ) (SPY ) Thursday closed up +0.32%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.68%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.44%. Stocks on Thursday...

$SPX : 5,099.96 (+1.02%)
SPY : 508.26 (+0.95%)
$DOWI : 38,239.66 (+0.40%)
DIA : 382.31 (+0.36%)
$IUXX : 17,718.30 (+1.65%)
QQQ : 431.00 (+1.54%)
ZNM24 : 107-185s (+0.20%)
MU : 114.84 (+2.92%)
WDC : 71.36 (+2.76%)
LRCX : 925.37 (+2.65%)
AMAT : 203.38 (+2.98%)
MRVL : 69.62 (+3.17%)
BridgeBio Pharma: Q4 Earnings Snapshot

BridgeBio Pharma: Q4 Earnings Snapshot

BBIO : 24.88 (+2.26%)
2 Biotechs That Could Get Bought Out in 2024

These two biotechs have been frequent visitors to the buyout-rumor mill and for good reason.

CYTK : 65.34 (+0.83%)
BBIO : 24.88 (+2.26%)
BridgeBio Pharma: Q3 Earnings Snapshot

BridgeBio Pharma: Q3 Earnings Snapshot

BBIO : 24.88 (+2.26%)
Why BridgeBio Pharma Was a Healthy Stock Today

One of the best-performing biotechs on the stock market this year gets a bullish nod from a researcher.

BBIO : 24.88 (+2.26%)
Markets Today: Stock Climb and Bond Yields Fall as Interest Rate Concerns Ease

Morning Markets September E-Mini S&P 500 futures (ESU2 3) this morning are up +0.45%, and Sep Nasdaq 100 E-Mini futures (NQU2 3) are up +0.59%. Stock indexes this morning are moderately higher on some...

ESM24 : 5,131.50s (+0.97%)
NQM24 : 17,845.75s (+1.58%)
MMM : 91.83 (+0.46%)
HZNP : 116.30 (+0.04%)
ZBH : 119.35 (-0.33%)
BBIO : 24.88 (+2.26%)
HE : 9.88 (-5.90%)
RPT : 12.83 (-2.51%)
BSX : 73.17 (-0.12%)
APPF : 242.75 (+12.05%)
CRWD : 304.07 (+2.03%)
NVCR : 12.64 (+3.31%)
Wall Street Thinks BridgeBio Pharma Could Rise Over 40% -- But Will It?

Its potential upcoming drug launch might not be enough.

BBIO : 24.88 (+2.26%)
BridgeBio Pharma: Q2 Earnings Snapshot

BridgeBio Pharma: Q2 Earnings Snapshot

BBIO : 24.88 (+2.26%)
Could This Stock Be the Next Biotech Buyout?

A buyout deal recently pushed Reata Pharmaceuticals stock 53% higher in a single trading session, leading investors to wonder who's next.

PFE : 25.40 (+0.55%)
RETA : 172.36 (+0.02%)
BIIB : 208.90 (+3.18%)
BBIO : 24.88 (+2.26%)
Why Shares of BridgeBio Pharma Skyrocketed This Week

The biotech company saw strong results in a phase 3 trial.

ALNY : 143.31 (-0.28%)
PFE : 25.40 (+0.55%)
BBIO : 24.88 (+2.26%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strengthening short term outlook on maintaining the current direction.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

BridgeBio Pharma Inc. discovers, develops and innovates drugs for genetic diseases. The Company's product platform consists of Mendelian, Oncology and Gene therapy. Its product pipeline includes BBP-265, BBP-831, BBP-631 and BBP-454 which are in clinical stage. BridgeBio Pharma Inc. is based in CA, United...

See More

Key Turning Points

3rd Resistance Point 25.81
2nd Resistance Point 25.40
1st Resistance Point 25.14
Last Price 24.88
1st Support Level 24.47
2nd Support Level 24.06
3rd Support Level 23.80

See More

52-Week High 44.32
Fibonacci 61.8% 32.26
Fibonacci 50% 28.53
Last Price 24.88
Fibonacci 38.2% 24.81
52-Week Low 12.75

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar